Terms: = Prostate cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Diagnosis
33 results:
1. Use of the Decipher genomic classifier among men with prostate cancer in the United States.
Zaorsky NG; Proudfoot JA; Jia AY; Zuhour R; Vince R; Liu Y; Zhao X; Hu J; Schussler NC; Stevens JL; Bentler S; Cress RD; Doherty JA; Durbin EB; Gershman S; Cheng I; Gonsalves L; Hernandez BY; Liu L; Morawski BM; Schymura M; Schwartz SM; Ward KC; Wiggins C; Wu XC; Shoag JE; Ponsky L; Dal Pra A; Schaeffer EM; Ross AE; Sun Y; Davicioni E; Petkov V; Spratt DE
JNCI Cancer Spectr; 2023 Aug; 7(5):. PubMed ID: 37525535
[TBL] [Abstract] [Full Text] [Related]
2. FTIR microspectroscopy and multivariate analysis facilitate identification of dynamic changes in epithelial-to-mesenchymal transition induced by TGF-β in prostate cancer cells.
Karmakar D; Lahiri P; Bedi M; Ghosh A; Ghosh A; Barui A; Varshney SK; Lahiri B; Sengupta S
J Cell Biochem; 2023 Jun; 124(6):849-860. PubMed ID: 37158093
[TBL] [Abstract] [Full Text] [Related]
3. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for prostate cancer.
Hamdy FC; Donovan JL; Lane JA; Metcalfe C; Davis M; Turner EL; Martin RM; Young GJ; Walsh EI; Bryant RJ; Bollina P; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Rosario DJ; Rowe E; Mason M; Catto JWF; Peters TJ; Oxley J; Williams NJ; Staffurth J; Neal DE;
N Engl J Med; 2023 Apr; 388(17):1547-1558. PubMed ID: 36912538
[TBL] [Abstract] [Full Text] [Related]
4. Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5-9.9 ng ml
Huang MP; Tang P; Klein CS; Wei XH; Du W; Fu JG; Huang TH; Chen H; Xie KJ
Asian J Androl; 2023; 25(1):82-85. PubMed ID: 35562126
[TBL] [Abstract] [Full Text] [Related]
5. prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
[TBL] [Abstract] [Full Text] [Related]
6. Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?
Lee J; Yang SW; Jin L; Lee CL; Lee JY; Shin JH; Lim JS; Song KH
BMC Cancer; 2021 Apr; 21(1):472. PubMed ID: 33910525
[TBL] [Abstract] [Full Text] [Related]
7. Opioid use by cancer status and time since diagnosis among older adults enrolled in the prostate, Lung, Colorectal, and Ovarian screening trial in the United States.
Durham DD; Strassels SA; Pinsky PF
Cancer Med; 2021 Mar; 10(6):2175-2187. PubMed ID: 33638315
[TBL] [Abstract] [Full Text] [Related]
8. The Use of Healthcare Services by prostate cancer Patients in the Last 12 Months of Life: How Do We Improve the Quality of Care During This Period?
Tien T; Gkougkousis E; Allchorne P; Green JSA
J Palliat Care; 2021 Apr; 36(2):93-97. PubMed ID: 33241737
[TBL] [Abstract] [Full Text] [Related]
9. Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007-2017.
Huang SY; Chen HM; Liao KH; Ko BS; Hsiao FY
BMJ Open; 2020 Oct; 10(10):e036341. PubMed ID: 33039986
[TBL] [Abstract] [Full Text] [Related]
10. Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank.
Wei J; Shi Z; Na R; Wang CH; Resurreccion WK; Zheng SL; Hulick PJ; Cooney KA; Helfand BT; Isaacs WB; Xu J
Br J Cancer; 2020 Oct; 123(9):1356-1359. PubMed ID: 32830201
[TBL] [Abstract] [Full Text] [Related]
11. Minimally invasive strategies for the treatment of prostate cancer recurrence after radiation therapy: a systematic review.
Mantica G; Chierigo F; Suardi N; Gomez Rivas J; Kasivisvanathan V; Papalia R; Fiori C; Porpiglia F; Terrone C; Esperto F;
Minerva Urol Nefrol; 2020 Oct; 72(5):563-578. PubMed ID: 32748617
[TBL] [Abstract] [Full Text] [Related]
12. Quality Comparison of 3 Tesla multiparametric MRI of the prostate using a flexible surface receiver coil versus conventional surface coil plus endorectal coil setup.
Ullrich T; Kohli MD; Ohliger MA; Magudia K; Arora SS; Barrett T; Bittencourt LK; Margolis DJ; Schimmöller L; Turkbey B; Westphalen AC
Abdom Radiol (NY); 2020 Dec; 45(12):4260-4270. PubMed ID: 32696213
[TBL] [Abstract] [Full Text] [Related]
13. Antihypertensive drug use and prostate cancer-specific mortality in Finnish men.
Siltari A; Murtola TJ; Talala K; Taari K; Tammela TLJ; Auvinen A
PLoS One; 2020; 15(6):e0234269. PubMed ID: 32598349
[TBL] [Abstract] [Full Text] [Related]
14. Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden.
George G; Garmo H; Rudman S; Holmberg L; Robinson D; Stattin P; Adolfsson J; Van Hemelrijck M
Scand J Urol; 2020 Feb; 54(1):20-26. PubMed ID: 31842658
[No Abstract] [Full Text] [Related]
15. A novel algorithm based on bi-random walks to identify disease-related lncRNAs.
Hu J; Gao Y; Li J; Zheng Y; Wang J; Shang X
BMC Bioinformatics; 2019 Nov; 20(Suppl 18):569. PubMed ID: 31760932
[TBL] [Abstract] [Full Text] [Related]
16. [The Advancement of Attenuated Total Reflection Fourier Transform Infrared Technology in Clinical Application].
Zhang XQ; Sun XL; Pan QH; Zhang YF; Xu Z; Guo XY
Guang Pu Xue Yu Guang Pu Fen Xi; 2017 Feb; 37(2):408-11. PubMed ID: 30265462
[TBL] [Abstract] [Full Text] [Related]
17. Enhanced detection sensitivity of prostate-specific antigen via PSA-conjugated gold nanoparticles based on localized surface plasmon resonance: GNP-coated anti-PSA/LSPR as a novel approach for the identification of prostate anomalies.
Jazayeri MH; Amani H; Pourfatollah AA; Avan A; Ferns GA; Pazoki-Toroudi H
Cancer Gene Ther; 2016 Oct; 23(10):365-369. PubMed ID: 27740614
[TBL] [Abstract] [Full Text] [Related]
18. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized prostate cancer.
Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Kockelbergh R; Kynaston H; Paul A; Powell P; Prescott S; Rosario DJ; Rowe E; Neal DE;
N Engl J Med; 2016 Oct; 375(15):1415-1424. PubMed ID: 27626136
[TBL] [Abstract] [Full Text] [Related]
19. Cardiovascular Disease Among Survivors of Adult-Onset cancer: A Community-Based Retrospective Cohort Study.
Armenian SH; Xu L; Ky B; Sun C; Farol LT; Pal SK; Douglas PS; Bhatia S; Chao C
J Clin Oncol; 2016 Apr; 34(10):1122-30. PubMed ID: 26834065
[TBL] [Abstract] [Full Text] [Related]
20. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After prostatectomy for High-Risk prostate cancer.
Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
[TBL] [Abstract] [Full Text] [Related]
[Next]
